• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化视网膜下注射的生物力学考虑因素。

Biomechanical considerations for optimising subretinal injections.

机构信息

Department of Eye and Vision Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.

Musculoskeletal and Ageing Science, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.

出版信息

Surv Ophthalmol. 2024 Sep-Oct;69(5):722-732. doi: 10.1016/j.survophthal.2024.05.004. Epub 2024 May 24.

DOI:10.1016/j.survophthal.2024.05.004
PMID:38797394
Abstract

Subretinal injection is the preferred delivery technique for various novel ocular therapies and is widely used because of its precision and efficient delivery of gene and cell therapies; however, choosing an injection point and defining delivery parameters to target a specified retinal location and area is an inexact science. We provide an overview of the key factors that play important roles during subretinal injections to refine the technique, enhance patient outcomes, and minimise risks. We describe the role of anatomical and physical variables that affect subretinal bleb propagation and shape and their impact on retinal integrity. We highlight the risks associated with subretinal injections and consider strategies to mitigate reflux and retinal trauma. Finally, we explore the emerging field of robotic assistance in improving intraocular manouvrability and precision to facilitate the injection procedure.

摘要

视网膜下注射是各种新型眼科治疗的首选给药技术,由于其精确性和高效性,基因和细胞治疗的给药,因此被广泛应用;然而,选择注射点并定义给药参数以靶向特定的视网膜位置和区域是一门不精确的科学。我们提供了在视网膜下注射中起重要作用的关键因素概述,以完善该技术,提高患者的治疗效果,并将风险最小化。我们描述了影响视网膜下气泡传播和形状的解剖和物理变量的作用,以及它们对视网膜完整性的影响。我们强调了与视网膜下注射相关的风险,并考虑了减轻反流和视网膜创伤的策略。最后,我们探讨了机器人辅助在改善眼内可操作性和精确性以促进注射过程中的新兴领域。

相似文献

1
Biomechanical considerations for optimising subretinal injections.优化视网膜下注射的生物力学考虑因素。
Surv Ophthalmol. 2024 Sep-Oct;69(5):722-732. doi: 10.1016/j.survophthal.2024.05.004. Epub 2024 May 24.
2
Head-mounted surgical robots are an enabling technology for subretinal injections.头戴式手术机器人是视网膜下注射的一项赋能技术。
Sci Robot. 2025 Feb 19;10(99):eadp7700. doi: 10.1126/scirobotics.adp7700.
3
Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse.小鼠优化微创经巩膜视网膜下注射技术
J Vis Exp. 2025 Jul 25(221). doi: 10.3791/68631.
4
AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery.玻璃体内和视网膜下注射后,AAV2和AAV9在小鼠眼睛及主要组织中的嗜性和转基因表达。
Front Drug Deliv. 2023 Jul 12;3:1148795. doi: 10.3389/fddev.2023.1148795. eCollection 2023.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Development of an image-guided non-vitrectomy subretinal access approach for trans-scleral cell and gene therapy delivery.用于经巩膜细胞和基因治疗递送的图像引导非玻璃体切割视网膜下通路方法的开发。
bioRxiv. 2025 Mar 1:2025.02.25.640217. doi: 10.1101/2025.02.25.640217.
7
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.眼内手术后急性眼内炎中辅助性皮质类固醇治疗与单独使用抗生素的比较。
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD012131. doi: 10.1002/14651858.CD012131.pub3.
8
pTau pathology in the retina of TAU58 mice: association with ganglion cell degeneration and implications on seeding and propagation of pTau from human brain lysates.TAU58小鼠视网膜中的pTau病理学:与神经节细胞变性的关联以及对来自人脑裂解物的pTau播种和传播的影响。
Acta Neuropathol Commun. 2024 Dec 20;12(1):194. doi: 10.1186/s40478-024-01907-8.
9
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure.辅助性类固醇疗法与单纯抗生素疗法治疗眼内手术后急性眼内炎的对比
Cochrane Database Syst Rev. 2017 Feb 22;2(2):CD012131. doi: 10.1002/14651858.CD012131.pub2.
10
Surgical interventions for bilateral congenital cataract in children aged two years and under.儿童两岁及以下双侧先天性白内障的手术干预。
Cochrane Database Syst Rev. 2022 Sep 15;9(9):CD003171. doi: 10.1002/14651858.CD003171.pub3.

引用本文的文献

1
Adeno-Associated Virus Vectors in Retinal Gene Therapy: Challenges, Innovations, and Future Directions.视网膜基因治疗中的腺相关病毒载体:挑战、创新与未来方向
Biomolecules. 2025 Jun 28;15(7):940. doi: 10.3390/biom15070940.
2
Advances in technical methods and applications of subretinal injections in experimental animals.实验动物视网膜下注射技术方法及应用的进展
Front Vet Sci. 2025 Apr 30;12:1574519. doi: 10.3389/fvets.2025.1574519. eCollection 2025.
3
12-month outcomes after voretigene neparvovec gene therapy in paediatric patients with -mediated inherited retinal dystrophy.
voretigene neparvovec基因治疗对介导性遗传性视网膜营养不良儿科患者的12个月疗效
Br J Ophthalmol. 2025 Jan 28;109(2):281-285. doi: 10.1136/bjo-2024-326221.